70934-696-30 : NDC 2026 Code

70934-696-30 : Amlodipine Besylate And Benazepril Hydrochloride ( Amlodipine Besylate And Benazepril Hydrochloride )

Additionally :

You can get information about “70934-696-30” NDC code in 70934-696-30 in HTML format

HTML | 70934-696-30 in TXT (Plain Text) format

TXT | 70934-696-30 in PDF (Portable Document Format)

PDF | 70934-696-30 in XML format

XML formats.

NDC Code : 70934-696-30 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "70934-696-30",
    "PackageDescription": "30 CAPSULE in 1 BOTTLE, PLASTIC (70934-696-30) ",
    "NDC11Code": "70934-0696-30",
    "ProductNDC": "70934-696",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Amlodipine Besylate And Benazepril Hydrochloride",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Amlodipine Besylate And Benazepril Hydrochloride",
    "DosageFormName": "CAPSULE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20200508",
    "EndMarketingDate": "20231231",
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA077183",
    "LabelerName": "Denton Pharma, Inc. dba Northwind Pharmaceuticals",
    "SubstanceName": "AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE",
    "StrengthNumber": "10; 20",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2024-01-02",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": null,
    "StartMarketingDatePackage": "20200508",
    "EndMarketingDatePackage": "20231231",
    "SamplePackage": "N"
  }
}